Issue Information

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

A Phase 1, Open‐Label, Single‐Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor
di: Wei Zhu, et al.
Pubblicazione: (2026)

First‐In‐Human Study to Assess the Pharmacokinetics and Safety of DS‐6016a After Single Subcutaneous Injection in Healthy Japanese Adults
di: Kei Okita, et al.
Pubblicazione: (2026)

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
di: Eugenio Mercuri, et al.
Pubblicazione: (2026)

Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions
di: Sudershan Kumar, et al.
Pubblicazione: (2026)

Effects of Cedirogant on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates
di: Ronilda D'Cunha, et al.
Pubblicazione: (2026)

Steady‐State Pharmacokinetic Properties of TNX‐102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open‐Label Trial
di: Gregory M. Sullivan, et al.
Pubblicazione: (2026)

A Human Mass Balance and Metabolism Study of [ 14 C]‐Ubrogepant in Healthy Male Adults
di: Ramesh R. Boinpally, et al.
Pubblicazione: (2026)

A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers
di: Angela Jeong, et al.
Pubblicazione: (2026)

Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs
di: Kyosuke Takahashi, et al.
Pubblicazione: (2026)

The Triple‐Agonist Revolution: Retatrutide and the Paradigm Shift in Multi‐Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities
di: Nila Ganamurali, et al.
Pubblicazione: (2026)

Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers
di: Bruce L Daugherty, et al.
Pubblicazione: (2026)

Safety, Tolerability, and Pharmacokinetics of Mufemilast, a PDE4 Inhibitor, in Healthy Participants: A First‐in‐Human Phase 1 Study
di: Xiuqi Li, et al.
Pubblicazione: (2026)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
di: Pan Luo, et al.
Pubblicazione: (2026)

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study
di: Vincent Chow, et al.
Pubblicazione: (2026)

LP‐001, a Novel Long‐Acting EPO‐Fc Fusion Protein: A Phase I Dose‐Escalation Study of Pharmacokinetics, Safety, and Tolerability in Healthy Chinese Subjects
di: Jie Yang, et al.
Pubblicazione: (2026)

Pharmacokinetics of Aztreonam–Avibactam After Single‐ and Multiple‐Dose Administration: A Phase 1, Open‐Label Study in Healthy Chinese Participants and Ethnic Comparison with Non‐Chinese Participants
di: Jingjing Wang, et al.
Pubblicazione: (2026)

The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
di: Amalia M. Issa
Pubblicazione: (2026)

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
di: Biao Sun, et al.
Pubblicazione: (2026)

From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities
di: Amalia M. Issa
Pubblicazione: (2026)